Ignite Creation Date:
2025-12-25 @ 1:13 AM
Ignite Modification Date:
2026-01-05 @ 2:35 PM
Study NCT ID:
NCT01863693
Status:
COMPLETED
Last Update Posted:
2018-09-17
First Post:
2013-05-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05-10
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-06-15
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-23
First Submit QC Date:
None
Study First Post Date:
2013-05-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-13
Last Update Post Date:
2018-09-17
Last Update Post Date Type:
ACTUAL